About Arylamine N-acetyltransferase 1
Arylamine N-acetyltransferase 1 (NAT1) is a protein
from Homo sapiens identified by UniProt accession
P18440, 290 residues long.
MolForge cross-references it against 0 known binders and
132 disease associations.
Target properties
| Protein name | Arylamine N-acetyltransferase 1 |
| UniProt accession | P18440 |
| Gene | NAT1 |
| Organism | Homo sapiens |
| Length | 290 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (132)
Diseases linked to this target (Open Targets).
- urate measurement · score 0.31
- bone density · score 0.31
- neurodegenerative disease · score 0.20
- breast cancer · score 0.09
- neoplasm · score 0.08
- glycogen storage disease due to lactate dehydrogenase H-subunit deficiency · score 0.07
- Isolated anophthalmia - microphthalmia · score 0.06
- triple-negative breast cancer · score 0.06
- microphthalmia · score 0.06
- cancer · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P18440-F1 | alphafold | PREDICTED | 98.19 | — |
Amino-acid sequence (290 residues)
MDIEAYLERI GYKKSRNKLD LETLTDILQH QIRAVPFENL NIHCGDAMDL GLEAIFDQVV RRNRGGWCLQ VNHLLYWALT TIGFETTMLG GYVYSTPAKK YSTGMIHLLL QVTIDGRNYI VDAGFGRSYQ MWQPLELISG KDQPQVPCVF RLTEENGFWY LDQIRREQYI PNEEFLHSDL LEDSKYRKIY SFTLKPRTIE DFESMNTYLQ TSPSSVFTSK SFCSLQTPDG VHCLVGFTLT HRRFNYKDNT DLIEFKTLSE EEIEKVLKNI FNISLQRKLV PKHGDRFFTI
Explore Arylamine N-acetyltransferase 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets